![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/13/2880276/0/en/Lycia-Therapeutics-Completes-106-6-Million-Series-C-Financing-to-Advance-Pipeline-of-LYTAC-Extracellular-Protein-Degraders-to-the-Clinic.html
https://lyciatx.com/lycia-therapeutics-completes-106-6-million-series-c-financing-to-advance-pipeline-of-lytac-extracellular-protein-degraders-to-the-clinic/
https://www.globenewswire.com/news-release/2023/06/05/2681828/0/en/Lycia-Therapeutics-to-Present-at-Jefferies-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2022/10/05/2528980/0/en/Lycia-Therapeutics-Founder-Dr-Carolyn-Bertozzi-Awarded-2022-Nobel-Prize-in-Chemistry.html
https://www.globenewswire.com/news-release/2022/02/28/2392954/0/en/Lycia-Therapeutics-Strengthens-Leadership-Team-with-Appointment-of-Steve-Staben-Ph-D-as-Chief-Scientific-Officer.html
https://www.fiercebiotech.com/biotech/lilly-backed-lycia-therapeutics-nabs-70m-round-for-its-protein-degradation-tech
https://www.fiercebiotech.com/biotech/lilly-doubles-down-protein-degradation-inking-35m-deal-lycia-and-promising-1-6b-more